SMI

About the SMI

The Swiss Market Index (SMI) is Switzerland’s most important stock market index, tracking the 20 largest and most liquid stocks listed on the SIX Swiss Exchange. Despite Switzerland’s relatively small population of around 9 million, the SMI contains some of the world’s most valuable companies, reflecting Switzerland’s outsized role in global pharmaceuticals, consumer goods, and financial services. The index is highly concentrated, with the three largest components (Nestle, Roche, and Novartis) historically accounting for over 50% of the total index weight. This extreme concentration gives the SMI a defensive, healthcare-and-consumer-heavy character that distinguishes it from more cyclical European indices like the DAX or CAC 40. Switzerland’s non-EU status, political stability, and strong currency add unique dimensions to SMI investing.

What Moves the SMI?

Healthcare Sector

Roche and Novartis, two of the world’s largest pharmaceutical companies, together represent roughly one-third of the SMI. Drug approval decisions, clinical trial results, patent expirations, and global healthcare policy developments are among the most impactful events for the index. The healthcare sector gives the SMI a defensive quality, as pharmaceutical demand tends to be relatively resistant to economic cycles.

Nestle and Consumer Staples

Nestle, the world’s largest food and beverage company, is the SMI’s biggest single component. Global food prices, consumer spending trends, and Nestle’s quarterly organic growth figures have a significant influence on the index. Nestle’s defensive characteristics complement the healthcare sector, reinforcing the SMI’s reputation as a lower-volatility European equity benchmark.

SNB Policy and Swiss Franc

Swiss National Bank monetary policy and CHF exchange rate movements affect SMI companies through multiple channels. A stronger franc makes Swiss exports more expensive and reduces the translated value of overseas earnings (most SMI companies derive the majority of revenue from abroad). SNB interest rate decisions and intervention stance therefore have both direct and indirect effects on the index.

Global Pharmaceutical and Consumer Trends

As a globally oriented index, the SMI responds to international trends in healthcare spending, drug pricing policy, nutritional science, and consumer behavior. US FDA decisions are particularly impactful for Roche and Novartis, while global food industry trends influence Nestle. European and global economic conditions affect the index’s smaller industrial and financial components.

Trading the SMI

The SMI is traded through futures on Eurex (SMI futures), ETFs, options, and CFDs. SIX Swiss Exchange trading hours are 09:00-17:30 CET. The SMI typically moves 0.5-1.0% daily, making it one of the lower-volatility European indices. This stability attracts investors seeking European equity exposure with defensive characteristics. The index is CHF-denominated, providing natural diversification for traders whose portfolios are dominated by USD or EUR assets. Key trading events include quarterly earnings from Nestle, Roche, and Novartis, SNB meetings, and global pharmaceutical regulatory decisions.